绝经期肌肉骨骼疾病的功能影像学
本文综述核医学在绝经相关肌肉骨骼疾病(骨质疏松、骨关节炎、肌肉减少症与肌肉减少性肥胖)功能成像中的应用。99mTc-膦酸盐骨扫描可识别年龄相关骨质疏松所致的新鲜椎体塌陷,18F-NaF PET动态扫描对测量骨转换和评估骨关节炎软骨下骨代谢活性有积极结果,FDG PET有助于鉴别病理性与非病理性椎体骨折并可成像炎症关节;结论指出需进一步研究明确核医学在绝经相关肌肉骨骼疾病中的作用。
要点
- 99mTc-膦酸盐骨扫描可识别年龄相关骨质疏松所致的新鲜椎体塌陷。
- 18F-NaF PET动态扫描对测量骨质疏松骨转换和骨关节炎软骨下骨代谢活性有积极结果。
- FDG PET可帮助鉴别病理性与非病理性椎体骨折,并成像骨关节炎炎症关节。
核心结论
- 需进一步研究以更好明确核医学在绝经相关肌肉骨骼疾病中的作用,尤其涉及新型放射性药物(如FAPI和RGD肽)和近期技术进展(如全身PET/CT扫描仪)的可能影响。
研究设计与样本
- 本文为综述,聚焦核医学在绝经相关肌肉骨骼疾病(骨质疏松、骨关节炎、肌肉减少症和肌肉减少性肥胖)功能成像中的应用。
主要发现
- 99mTc标记膦酸盐骨扫描单独或联合MRI可识别年龄相关骨质疏松所致的新鲜椎体塌陷,并在骨关节炎患者中提供与放射学指标良好相关的定量参数。
- 18F-NaF PET尤其动态扫描对测量骨质疏松骨转换有积极结果,并可评估骨关节炎软骨下骨代谢活性。
- FDG PET可帮助鉴别病理性与非病理性椎体骨折,尤其通过应用适当的基于SUV的阈值。
- 在骨关节炎中,FDG PET可有效成像炎症关节并支持适当的临床管理。
- 初步证据提示FDG可能用于肌肉减少性肥胖中内脏脂肪组织(VAT)的检测和定量。
局限性
- 需进一步研究以更好明确核医学在绝经相关肌肉骨骼疾病中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Menopause-related musculoskeletal (MSK) disorders include osteoporosis, osteoarthritis (OA), sarcopenia and sarco-obesity. This review focuses on the applications of nuclear medicine for the functional imaging of the aforementioned clinical conditions. Bone Scan (BS) with 99mTc-labeled phosphonates, alone or in combination with MRI, can identify "fresh" vertebral collapse due to age-associated osteoporosis and provides quantitative parameters characterized by a good correlation with radiological indices in patients with OA. 18F-NaF PET, particularly when performed by dynamic scan, has given encouraging results for measuring bone turnover in osteoporosis and allows the evaluation of subchondral bone metabolic activity in OA. FDG PET can help discriminate between pathological and nonpathological vertebral fractures, especially by applying appropriate SUV-based thresholds. In OA, it can effectively image inflamed joints and support appropriate clinical management. Preliminary evidences suggest a possible application of FDG in sarco-obesity for the detection and quantification of visceral adipose tissue (VAT). Further studies are needed to better define the role of nuclear medicine in menopause-related MSK disease, especially as regards the possible impact of new radiopharmaceuticals (ie, FAPI and RGD peptides) and recent technological advances (eg, total-body PET/CT scanners).
引用
- Filippi L, Camedda R, Frantellizzi V, et al. Functional Imaging in Musculoskeletal Disorders in Menopause. Semin Nucl Med. 2023. PMID: 37914617. doi:10.1053/j.semnuclmed.2023.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。